Meiji Seika Pharmatech Co., Ltd.

FDA inspection history in Odawara, Japan, 2022

1
Form 483

Every document, by year

  • Form 483

2022: one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2022One Form 483, at Odawara, Japan.

Cited most

Across all Meiji Seika Pharmatech Co. observations on file

The complete Meiji Seika Pharmatech Co. file.

All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.

$99

The documents one by one, while the file is prepared

See the documents

Sites

Documents

1 on file, newest first
DateDocumentPrice
2022-04-08483 Form 483$99

Investigators on these documents

Teresa I. Navas (1)

FEI number 3015407855 · most recent document Apr 8, 2022

About Meiji Seika Pharmatech Co., Ltd.

How many FDA Form 483s has Meiji Seika Pharmatech Co., Ltd. received?

FDA Intel has 1 Form 483 on file for Meiji Seika Pharmatech Co., Ltd.; the most recent is dated Apr 8, 2022.

When was Meiji Seika Pharmatech Co., Ltd. last inspected by FDA?

The most recent FDA inspection document on file for Meiji Seika Pharmatech Co., Ltd. is a Form 483 dated Apr 8, 2022, for the site in Odawara, Japan.

What did FDA cite at Meiji Seika Pharmatech Co., Ltd.?

The regulations cited most in the observations on file for Meiji Seika Pharmatech Co., Ltd. are 21 CFR 211.100 (Written procedures; deviations), 1 time; 21 CFR 211.192 (Production record review), 1 time; 21 CFR 211.22 (Responsibilities of quality control unit), 1 time.